Research Research and Professional Briefs| Volume 112, ISSUE 7, P1062-1067, July 2012

Absorption of Folic Acid from a Softgel Capsule Compared to a Standard Tablet


      Consumption of 400 μg folic acid per day from fortified foods and/or supplements, plus food folate from a varied diet is recommended for women of childbearing potential to reduce the risk for neural tube defects during fetal development. This randomized crossover study was designed to evaluate the bioavailability of folic acid from a multivitamin softgel capsule vs a folic acid tablet in 16 premenopausal women (18 to 45 years of age). Participants were randomly assigned to receive a single dose of ∼1,000 μg folic acid in two tablets or ∼1,000 μg folic acid in a multivitamin softgel capsule, and then crossed over to receive the other study product ∼1 week later. Products were administered with a low-folate breakfast. Blood samples were collected predose (0 hour) and 1, 2, 3, 4, 6, and 8 hours post-dose for serum folate analysis. Repeated measures analysis of variance was used to compare responses between treatments. Data from the two sequence groups (n=8 per sequence) were pooled. Mean serum folate total and net incremental areas under the curve (AUC0-8 hours) were not significantly different between tablets and softgel capsule (AUC0-8 hours 214.9±11.2 hours×ng/mL [487±25.4 hours×nmol/L] and 191.6±13.3 hours×ng/mL [434.2±30.1 hours×nmol/L]; net incremental AUC0-8 hours 117.3±8.5 hours×ng/mL [265.8±19.3 hours×nmol/L] and 105.8±12.5 hours×ng/mL [239.7±28.3 hours×nmol/L], respectively), nor was maximum folate concentration (45.1±2.5 ng/mL [102.2±5.7 nmol/L] and 42.5±3.8 ng/mL [96.3±8.6 nmol/L], respectively). Time to peak folate concentration was significantly (P<0.001) delayed for the softgel capsule vs tablet (3.9±0.3 vs 1.7±0.2 hours, respectively). In conclusion, apparent bioavailability of folic acid was similar for the folic acid tablets and a multivitamin softgel capsule.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Medical Research Council Vitamin Study Research Group
        Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study.
        Lancet. 1991; 338: 131-137
        • Food and Nutrition Board, Institute of Medicine
        Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. A report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients.
        in: National Academies Press, Washington, DC1998: 196-305
        • Tamura T.
        • Picciano M.F.
        Folate and human reproduction.
        Am J Clin Nutr. 2006; 83: 993-1016
        • Wolff T.
        • Witkop C.T.
        • Miller T.
        • Syed S.B.
        Folic acid supplementation for the prevention of neural tube defects: An update of the evidence for the US Preventive Services Task Force.
        Agency for Healthcare Research and Quality, Rockville, MD2009 May (Evidence Syntheses, no. 70)
        • Blencowe H.
        • Cousens S.
        • Modell B.
        • Lawn J.
        Folic acid to reduce neonatal mortality from neural tube disorders.
        Int J Epidemiol. 2010; 39: i110-i121
        • Czeizel A.E.
        • Dudás I.
        Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.
        N Engl J Med. 1992; 327: 1832-1835
        • Wolff T.
        • Witkop C.T.
        • Miller T.
        • Syed S.B.
        • US Preventive Services Task Force
        Folic acid supplementation for the prevention of neural tube defects: An update of the evidence for the US Preventive Services Task Force.
        Ann Intern Med. 2009; 150: 632-639
        • Sauberlich H.E.
        • Kretsch M.J.
        • Skala J.H.
        • Johnson H.L.
        • Taylor P.C.
        Folate requirement and metabolism in nonpregnant women.
        Am J Clin Nutr. 1987; 46: 1016-1028
        • US Food and Drug Administration
        Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid: Final rule, (21 CFR Parts 136, 137, 139).
        Fed Reg. 1996; 61: 8781-8797
        • Health Canada
        Regulations amending the Food and Drug Regulations, Schedule No. 1066.
        Canada Gazette. 1997; 131 (Part 1) (Accessed November 25, 2011): 1509-1519
        • Public Health Agency of Canada
        Evaluation of food fortification with folic acid for the primary prevention of neural tube defects.
        (Accessed November 25, 2011)
        • McNulty H.
        • Pentieva K.
        Folate bioavailability.
        Proc Nutr Soc. 2004; 63: 529-536
        • McNulty H.
        • Scott J.M.
        Intake and status of folate and related B-vitamins: Considerations and challenges in achieving optimal status.
        Br J Nutr. 2008; 99: S48-S54
        • Lawrence M.A.
        • Chai W.
        • Kara R.
        • Rosenberg I.H.
        • Scott J.
        • Tedstone A.
        Examination of selected national policies towards mandatory folic acid fortification.
        Nutr Rev. 2009; 67: S73-S78
        • Tinker S.C.
        • Cogswell M.E.
        • Devine O.
        • Berry R.J.
        Folic acid intake among US women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006.
        Am J Prev Med. 2010; 38: 534-542
        • Jones 3rd, W.J.
        • Francis J.J.
        Softgels: Consumer perceptions and market impact relative to other oral dosage forms.
        Adv Ther. 2000; 17: 213-221
        • Hoag S.W.
        • Ramachandruni H.
        • Shangraw R.F.
        Failure of prescription prenatal vitamin products to meet USP standards for folic acid dissolution.
        J Am Pharm Assoc (Wash.). 1997; NS37: 397-400
        • Giebe K.
        • Counts C.
        Comparison of Prenate Advance with other prescription prenatal vitamins: A folic acid dissolution study.
        Adv Ther. 2000; 17: 179-183
        • Sculthorpe N.F.
        • Davies B.
        • Ashton T.
        • Allison S.
        • McGuire D.N.
        • Malhi J.S.
        Commercially available folic acid supplements and their compliance with the British Pharmacopoeia test for dissolution.
        J Public Health Med. 2001; 23: 195-197
        • Srinivasan V.S.
        Bioavailability of nutrients: A practical approach to in vitro demonstration of the availability of nutrients in multivitamin-mineral combination products.
        J Nutr. 2001; 131: 1349S-1350S
        • Du J.
        • Hoag S.W.
        Characterization of excipient and tableting factors that influence folic acid dissolution, friability, and breaking strength of oil-and water-soluble multivitamin with minerals tablets.
        Drug Dev Ind Pharm. 2003; 29: 1137-1147
        • Melse-Boonstra A.
        • West C.E.
        • Katan M.B.
        • Kok F.J.
        • Verhoef P.
        Bioavailability of heptaglutamyl relative to monoglutamyl folic acid in healthy adults.
        Am J Clin Nutr. 2004; 79: 424-429
        • Pentieva K.
        • McNulty H.
        • Reichert R.
        • et al.
        The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men.
        J Nutr. 2004; 134: 580-585
        • Löbenberg R.
        • Steinke W.
        Investigation of vitamin and mineral tablets and capsules on the Canadian market.
        J Pharm Pharm Sci. 2006; 9: 40-49
        • Yetley E.A.
        Multivitamin and multimineral dietary supplements: Definitions, characterization, bioavailability, and drug interactions.
        Am J Clin Nutr. 2007; 85: 269S-276S
        • Hartman-Craven B.
        • Christofides A.
        • O'Connor D.L.
        • Zlotkin S.
        Relative bioavailability of iron and folic acid from a new powdered supplement compared to a traditional tablet in pregnant women.
        BMC Pregnancy Childbirth. 2009; 9: 33
        • Younis I.R.
        • Stamatakis M.K.
        • Callery P.S.
        • Meyer-Stout P.J.
        Influence of pH on the dissolution of folic acid supplements.
        Int J Pharm. 2009; 367: 97-102
        • Póo-Prieto R.
        • Haytowitz D.B.
        • Holden J.M.
        • et al.
        Use of the affinity/HPLC method for quantitative estimation of folic acid in enriched cereal-grain products.
        J Nutr. 2006; 136: 3079-3083
        • Brouns F.
        • Bjorck I.
        • Frayn K.N.
        • et al.
        Glycaemic index methodology.
        Nutr Res Rev. 2005; 18: 145-171
        • Shapiro S.S.
        • Wilk M.B.
        An analysis of variance test for normality (complete samples).
        Biometrika. 1965; 52: 591-611
        • Ghishan F.K.
        • Said H.M.
        • Wilson P.C.
        • Murrell J.E.
        • Greene H.L.
        Intestinal transport of zinc and folic acid: A mutual inhibitory effect.
        Am J Clin Nutr. 1986; 43: 258-262
        • Kauwell G.P.
        • Bailey L.B.
        • Gregory 3rd, J.F.
        • Bowling D.W.
        • Cousins R.J.
        Zinc status is not adversely affected by folic acid supplementation and zinc intake does not impair folate utilization in human subjects.
        J Nutr. 1995; 125: 66-72
        • Keating J.N.
        • Wada L.
        • Stokstad E.L.
        • King J.C.
        Folic acid: Effect on zinc absorption in humans and in the rat.
        Am J Clin Nutr. 1987; 46: 835-839
        • Butterworth Jr, C.E.
        • Tamura T.
        Folic acid safety and toxicity: A brief review.
        Am J Clin Nutr. 1989; 50: 353-358
        • Hoag S.W.
        • Hussain A.S.
        The impact of formulation on bioavailability: Summary of workshop discussion.
        J Nutr. 2001; 131: 1389S-1391S
        • Oner L.
        • Arcasoy A.
        • Kas H.S.
        • Hincal A.A.
        Studies on zinc sulphate microcapsules: (III) In vivo evaluation.
        Eur J Drug Metab Pharmacokinet. 1989; 14: 107-110
        • Bhagavan H.N.
        • Wolkoff B.I.
        Correlation between the disintegration time and the bioavailability of vitamin C tablets.
        Pharm Res. 1993; 10: 239-242
        • Simmons W.K.
        • Cook J.D.
        • Bingham K.C.
        • et al.
        Evaluation of a gastric delivery system for iron supplementation in pregnancy.
        Am J Clin Nutr. 1993; 58: 622-626
        • Navarro M.
        • Wood R.J.
        Plasma changes in micronutrients following a multivitamin and mineral supplement in healthy adults.
        J Am Coll Nutr. 2003; 22: 124-132
      1. The United States Pharmacopeial Convention 2010. {2040} Disintegration and dissolution of dietary supplements. Revision bulletin. Official March 2, 2010.
        (Accessed December 19, 2010)
        • Pietrzik K.
        • Bailey L.
        • Shane B.
        Folic acid and L-methyltetrahydrofolate: Comparison of clinical pharmacokinetics and pharmacodynamics.
        Clin Pharmacokinet. 2010; 49: 535-548
        • Whitehead V.M.
        • Cooper B.A.
        Absorption of unaltered folic acid from the gastro-intestinal tract in man.
        Br J Haematol. 1967; 13: 679-686
        • Wright A.J.
        • Finglas P.M.
        • Dainty J.R.
        • et al.
        Differential kinetic behavior and distribution for pteroylglutamic acid and reduced folates: A revised hypothesis of the primary site of PteGlu metabolism in humans.
        J Nutr. 2005; 135: 619-623
        • King J.C.
        Effect of reproduction on the bioavailability of calcium, zinc, and selenium.
        J Nutr. 2001; 131: 1355S-1358S
        • Krebs N.F.
        Bioavailability of dietary supplements and impact of physiologic state: Infants, children and adolescents.
        J Nutr. 2001; 131: 1351S-1354S
        • Solomons N.
        • Slavin J.L.
        What impact does stage of physiological development and/or physiological state have on the bioavailability of dietary supplements?.
        J Nutr. 2001; 131: 1392S-1395S
        • Winkels R.M.
        • Brouwer I.A.
        • Siebelink E.
        • Katan M.B.
        • Verhoef P.
        Bioavailability of food folates is 80% of that of folic acid.
        Am J Clin Nutr. 2007; 85: 465-473
        • Pfeiffer C.M.
        • Rogers L.M.
        • Bailey L.B.
        • Gregory 3rd, J.F.
        Absorption of folate from fortified cereal-grain products and of supplemental folate consumed with or without food determined by using a dual-label stable-isotope protocol.
        Am J Clin Nutr. 1997; 66: 1388-1397
      2. USP34-NF29.
        in: The United States Pharmacopeial Convention. United Book Press, Inc, Baltimore, MD2011: 1292-1316 (2911)
      3. Special tabulations of data from Finer and Henshaw.
        Perspectives on Sexual and Reproductive Health. 2006; 38 (Accessed November 25, 2011): 90-96


      K. C. Maki is president and chief science officer, Biofortis Clinical Research, Addison, IL.


      K. M. Kelley is clinical investigator, Biofortis Clinical Research, Addison, IL.


      A. L. Lawless is clinical investigator, Biofortis Clinical Research, Addison, IL.


      J. M. Shields is project manager, Biofortis Clinical Research, Addison, IL.


      M. R. Dicklin is associate director of medical writing, Biofortis Clinical Research, Addison, IL.


      L. I. Ndife is director of medical and scientific affairs, Pharmavite, LLC, Northridge, CA.


      J. R. Brooks is vice president, science and technology, Pharmavite, LLC, Northridge, CA.


      S. B. Wright is a registered dietitian and nutrition education specialist, Pharmavite, LLC, Northridge, CA.